The close correlation of vascular TGF-β-induced SMAD2/3 phosphorylation and the severity of vasculopathy is supported by recent genome wide association, and systems biology studies identified the TGF-β–SMAD pathway to be strongly associated with coronary artery disease (Zeng et al., 2016). Here, TGFB1 is linked to vascular disorder.